Please see below for a list of search results.
The HTA was asked to provide information on whether the company ‘Celixir’ had an HTA licence from 2010-13, for importing blood from patients at the Morriston Hospital and deriving mesenchymal stromal cells for research purposes.
The Human Tissue Authority is now consulting on a revised Code of Practice for organ and tissue donation and transplant professionals on the new Organ Donation (Deemed Consent) Act 2019.
The HTA is an executive Non-Departmental Public Body sponsored by the Department of Health and Social Care (DHSC), established by the Human Tissue Act 2004.
To make the most effective use of people and resources in pursuit of our goals.
Our deployment objectives for 2019/20 are to:
To make the right investment to continuously improve delivery and deployment.
Our development objectives for 2019/20 are to:
To deliver the right mix of activity to maintain public and professional confidence in the safe and proper use of human tissue.
The HTA’s high-level aims, objectives and high-level milestones and deliverables for 2019/20 are set out in this section. This information is supported by our key performance indicators (KPIs) at the end of this Plan, which set out how we will measure whether we are achieving those aims.